CardioNXT

Executive Summary

CardioNXT is a private medical device company based in Minneapolis, developing a next-generation 3D mapping and navigation system for cardiac electrophysiology (EP) procedures. Its iMap System is designed to integrate with advanced catheters, including pulsed field ablation (PFA) devices, to treat arrhythmias such as atrial fibrillation. The technology enables zero-fluoroscopy procedures, reducing radiation exposure for patients and physicians, and offers custom integrations for next-generation ablation tools. With a focus on improving the accuracy and safety of complex EP procedures, CardioNXT addresses a growing market for minimally invasive cardiac interventions.

Upcoming Catalysts (preview)

• Q3 2026First commercial sales of iMap System in the US75% success
• Q4 2026Strategic partnership with a major PFA catheter manufacturer60% success
• Q1 2027FDA clearance for expanded indication (e.g., ventricular tachycardia mapping)50% success